Metastatic Breast Cancer: Optimizing Care Through Clinical Pathways

Learning Objectives:

• Summarize current and recently approved agents and combinations for the systemic treatment of metastatic breast cancer
• Describe the challenges of creating and implementating clinical pathways in the complex pathophysiologic and therapeutic landscape of advanced breast cancer
• Develop clinical pathways for advanced and metastatic breast cancer to optimize evidence-based and cost-effective treatments
• Cultivate an understanding of barriers to care and obstacles to pathway implementation within the community in order to determine ways to improve patient access to HCC screening, diagnostic, and treatment services, as well as increase patient awareness and understanding of the condition